Xue, SA; Gao, LQ; Thomas, S et al.
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID miceHAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 95. H. 1. 2010 S. 126-134
Taube, C; Buhl, R
Does phenotyping asthma help to improve differential treatment?DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 135. H. 10. 2010 S. 468-473
Meyer, RG; Wagner, EM; Konur, A et al.
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantationBONE MARROW TRANSPLANTATION. Bd. 45. H. 4. 2010 S. 668-674
Caucig, P; Teschner, D; Dinges, S et al.
Dual Role of Interleukin-1 alpha in Delayed-Type Hypersensitivity and Airway HyperresponsivenessINTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. Bd. 152. H. 4. 2010 S. 303-312
Bruggenjurgen, B; Ezzat, N; Kardos, P et al.
Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatmentALLERGY. Bd. 65. H. 9. 2010 S. 1108-1115
Tautzenberger, A; Lorenz, S; Kreja, L et al.
Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiationBIOMATERIALS. Bd. 31. H. 8. 2010 S. 2064-2071
Adler, H; Kryczanowsky, F; Hermann, F et al.
Effect of IL-10-modulated tolerogenic DC in a humanized mouse model of lethal GvHDJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 130. 2010 S. S34-S34
Korn, S; Schumann, C; Kropf, C et al.
Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthmaANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. Bd. 105. H. 4. 2010 S. 313-319
Dahl, R; Chung, KF; Buhl, R et al.
Efficacy of a new once-daily long-acting inhaled beta(2)-agonist indacaterol versus twice-daily formoterol in COPDTHORAX. Bd. 65. H. 6. 2010 S. 473-479
Claus, M; Weber, M; Münster, E et al.
Einflussfaktoren auf den Sterbeort in Rheinland-Pfalz: Ergebnisse der EPACS-StudieZeitschrift für Palliativmedizin. Bd. 11. H. 5. 2010 S. 248